Leyland-Jones B, Vercammen E, Xiu L
J Clin Oncol. 2016; 34(31):3820-3821.
PMID: 27507880
PMC: 5477934.
DOI: 10.1200/JCO.2016.68.7681.
Ustundag S, Dogan E, Duranay M, Kazancioglu R, Celik V, Unsal A
Balkan Med J. 2016; 33(3):322-30.
PMID: 27308077
PMC: 4898992.
DOI: 10.5152/balkanmedj.2016.141173.
Pavlovic D, Savic-Radojevic A, Pljesa-Ercegovac M, Radic T, Ristic S, Coric V
Int Urol Nephrol. 2016; 48(2):257-63.
PMID: 26725075
DOI: 10.1007/s11255-015-1192-9.
Duman N, Uyanik A, Unsal A, Sezer S, Camsari T, Cirit M
Clin Kidney J. 2014; 7(5):464-9.
PMID: 25504109
PMC: 4257910.
DOI: 10.1093/ckj/sfu079.
Bratescu L, Barsan L, Garneata L, Stanciu A, Lipan M, Stancu S
Int Urol Nephrol. 2014; 46(5):1005-12.
PMID: 24800994
DOI: 10.1007/s11255-014-0696-z.
Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients.
Bristoyiannis G, Germanos N, Grekas D, Hatzidimitriou C, Iatrou C, Memmos D
Curr Ther Res Clin Exp. 2014; 66(3):195-211.
PMID: 24672123
PMC: 3964579.
DOI: 10.1016/j.curtheres.2005.06.009.
Partially thrombosed aneurysm of the abdominal aorta: Unusual cause of chronic inflammation and resistance to recombinant human erythropoietin.
Amrani M, El Kharras A, Asserraji M
Indian J Nephrol. 2014; 24(1):38-40.
PMID: 24574630
PMC: 3927190.
DOI: 10.4103/0971-4065.125069.
Urinary protein patterns in patients with Balkan endemic nephropathy.
Djukanovic L, Djordjevic V, Lezaic V, Cukuranovic R, Maric I, Bukvic D
Int Urol Nephrol. 2013; 45(6):1661-9.
PMID: 23877662
DOI: 10.1007/s11255-013-0499-7.
Evidence-based practice guideline for the treatment of CKD.
Clin Exp Nephrol. 2009; 13(6):537-66.
PMID: 19960305
DOI: 10.1007/s10157-009-0237-8.
Use of agents stimulating erythropoiesis in digestive diseases.
Moreno Lopez R, Aladren B, Gomollon Garcia F
World J Gastroenterol. 2009; 15(37):4675-85.
PMID: 19787831
PMC: 2754516.
DOI: 10.3748/wjg.15.4675.
Kidney disease: improving global outcomes.
Eckardt K, Kasiske B
Nat Rev Nephrol. 2009; 5(11):650-7.
PMID: 19786993
DOI: 10.1038/nrneph.2009.153.
Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial).
Barraclough K, Noble E, Leary D, Brown F, Hawley C, Campbell S
BMC Nephrol. 2009; 10:20.
PMID: 19635169
PMC: 2723098.
DOI: 10.1186/1471-2369-10-20.
Anaemia management with subcutaneous epoetin delta in patients with chronic kidney disease (predialysis, haemodialysis, peritoneal dialysis): results of an open-label, 1-year study.
Frei U, Kwan J, Spinowitz B
BMC Nephrol. 2009; 10:5.
PMID: 19243619
PMC: 2664800.
DOI: 10.1186/1471-2369-10-5.
IGF-1 is an independent risk factor for anemia in diabetic pre-dialysis patients.
Kim D, Kim T, Kim S, Yoo S, Oh D, Yu S
Korean J Intern Med. 2007; 22(3):186-91.
PMID: 17939336
PMC: 2687688.
DOI: 10.3904/kjim.2007.22.3.186.
Assessing a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency.
Allenet B, Chen C, Romanet T, Vialtel P, Calop J
Pharm World Sci. 2007; 29(1):7-11.
PMID: 17268940
DOI: 10.1007/s11096-005-4800-4.
The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy.
Thomas C, Kirschbaum A, Boehm D, Thomas L
Med Oncol. 2006; 23(1):23-36.
PMID: 16645227
DOI: 10.1385/MO:23:1:23.
Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients.
Luthi J, Flanders W, Burnier M, Burnand B, McClellan W
BMC Nephrol. 2006; 7:3.
PMID: 16515712
PMC: 1413523.
DOI: 10.1186/1471-2369-7-3.
Elderly patients on chronic hemodialysis with hyperparathyroidism: increase of hemoglobin level after intravenous calcitriol.
Neves P, Trivino J, Casaubon F, Santos V, Mendes P, Romao P
Int Urol Nephrol. 2006; 38(1):175-7.
PMID: 16502078
DOI: 10.1007/s11255-004-1563-0.
Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease.
Deicher R, Horl W
Drugs. 2004; 64(5):499-509.
PMID: 14977387
DOI: 10.2165/00003495-200464050-00004.
Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage.
Port R, Kiepe D, Van Guilder M, Jelliffe R, Mehls O
Clin Pharmacokinet. 2004; 43(1):57-70.
PMID: 14715051
DOI: 10.2165/00003088-200443010-00004.
